L Visit www.lifebiosciences.com →
Founded2017
HQBoston, Massachusetts
RoleDeveloper of cellular-rejuvenation gene therapies; lead candidate ER-100, the first partial epigenetic reprogramming therapy cleared by the FDA for a human trial.
Categorylongevity biotech
The lenses
Scored on its own merits — not rolled up from the finds we publish.
Novelty 4
Impact · breadth 2
Impact · depth 4
Actionable 2
Substance 4
Hype 3
Related concepts
Appears in finds
Top 5 · Life Biosciences
Lens
Window
Theme
Overall = breadth + depth + substance + ½·novelty + freshness (a small boost that halves each week)
01 
See the full feed → paperLongevity & Health
The clock turns back in a human eye
For the first time, a therapy meant to make old cells biologically younger — not repair them, but reset them — has been dosed into a living person, starting with the eye.
Overall▅▃▅▂▄▄medium · independentLife Biosciences
No finds in this window — widen it to see more.
How this connects
Tap a node to open it
Life BiosciencesLongevity & HealthBiotech & Synthetic BiologyThe clock turns back in a human eyeEpigenetic reprogrammingGene therapyHuman EnhancementDemis HassabisJennifer DoudnaEli LillyAlphabetOpenAIJ. Craig Venter InstituteThe edit that lowers cholesterolInsilico MedicineVERVE-102Verve TherapeuticsCRISPR that makes its own couriersUnited TherapeuticsColossal BioscienceseGenesisVITARI